Quantitative measurement of telomerase reverse transcriptase (hTERT) mRNA in urothelial cell carcinomas

International Journal of Cancer

Volumn 87, Issue 2, 2000, Pages 217-220

  De Kok, Jacques B ^a   Schalken, Jack A ^a   Aalders, Tilly W ^a   Ruers, Theo J M ^a   Willems, Hans L ^a   Swinkels, Dorine W ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RNA DIRECTED DNA POLYMERASE; TELOMERASE;

ARTICLE; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME ANALYSIS; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; RNA ANALYSIS; UROGENITAL TRACT CANCER;

CARCINOMA, TRANSITIONAL CELL; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; HUMANS; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS; RNA; RNA, MESSENGER; TELOMERASE; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 0034662113     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000715)87:2<217::AID-IJC10>3.0.CO;2-2     Document Type: Article

References (32)

1. BLOMJOUS, C.E., SMEULDERS, A.W., BAAK, J.P., VOS, W., VAN GALEN, C.M., and MEIJER, C.J., A comparative study in morphometric grading of transitional cell carcinoma of the urinary bladder. Anal. quant. Cytol. Histol., 11, 426-432 (1989).
2. CORDON-CARDO, C., Cell cycle regulators as prognostic factors for bladder cancer. Europ. J. Urol., 33(Suppl. 4), 11-12 (1998a).
3. CORDON-CARDO, C., Molecular alterations in bladder cancer. Cancer Surv., 32, 115-131 (1998b).
4. DE KOK, J.B., ZENDMAN, A.J., VAN DE LOCHT, L.T., RUERS, T.J.M., VAN MUIJEN, G.N., MENSINK, E., and SWINKELS, D.W., Real-time hTERT quantification: a promising telomerase-associated tumor marker. Lab. Invest., 79, 911-912 (1999).
5. DOME, J.S., CHUNG, S., BERGEMANN, T., UMBRICHT, C.B., SAJI, M., CAREY, L.A., GRUNDY, P.E., PERLMAN, E.J., BRESLOW, N.E., and SUKUMAR, S., High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor. Cancer Res., 59, 4301-4307 (1999).
6. DORKIN, T.J., ROBSON, C.N., and NEAL, D.E., The molecular pathology of urological malignancies. J. Pathol., 183, 380-387 (1997).
7. HEID, C.A., STEVENS, J., LIVAK, K.J., and WILLIAMS, P.M., Real time quantitative PCR. Genome Res., 6, 986-994 (1996).
8. HEINE, B., HUMMEL, M., MULLER, M., HEICAPPELL, R., MILLER, K., and STEIN, H., Non-radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine. J. Pathol., 184, 71-76 (1998).
9. ITO, H., KYO, S., KANAYA, T., TAKAKURA, M., INOUE, M., and NAMIKI, M., Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer. Clin. Cancer Res., 4, 1603-1608 (1998a).
10. ITO, H., KYO, S., KANAYA, T., TAKAKURA, M., KOSHIDA, K., NAMIKI, M., and INOUE, M., Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer. Clin. Cancer Res., 4, 2807-2810 (1998b).
11. KILIAN, A., BOWTELL, D.D., ABUD, H.E., HIME, G.R., VENTER, D.J., KEESE, P.K., DUNCAN, E.L., REDDEL, R.R., and JEFFERSON, R.A., Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum. mol. Genet., 6, 2011-2019 (1997).
12. KIM, N.W., PIATYSZEK, M.A., PROWSE, K.R., HARLEY, C.B., WEST, M.D., HO, P.L., COVIELLO, G.M., WRIGHT, W.E., WEINRICH, S.L., and SHAY, J.W., Specific association of human telomerase activity with immortal cells and cancer. Science, 266, 2011-2015 (1994).
13. KIM, N.W., and WU, F., Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res., 25, 2595-2597 (1997).
14. KROFT, S.H., and OYASU, R., Urinary bladder cancer: mechanisms of development and progression. Lab. Invest., 71, 158-174 (1994).
15. KYO, S., KANAYA, T., TAKAKURA, M., TANAKA, M., YAMASHITA, A., INOUE, H., and INOUE, M., Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors. Int. J. Cancer, 80, 804-809 (1999).
16. KYO, S., KUNIMI, K., UCHIBAYASHI, T., NAMIKI, M., and INOUE, M., Telomerase activity in human urothelial tumors. Amer. J. clin. Pathol., 107, 555-560 (1997).
17. LIN, Y., MIYAMOTO, H., FUJINAMI, K., UEMURA, H., HOSAKA, M., IWASAKI, Y., and KUBOTA, Y., Telomerase activity in human bladder cancer. Clin. Cancer Res., 2, 929-932 (1996).
18. MEYERSON, M., COUNTER, C.M., EATON, E.N., ELLISEN, L.W., STEINER, P., CADDLE, S.D., ZIAUGRA, L., BEIJERSBERGEN, R.L., DAVIDOFF, M.J., LIU, Q., BACCHETTI, S., HABER, D.A., and WEINBERG, R.A., HEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and DURING IMMORTALIZATION. Cell, 90, 785-795 (1997).
19. MOSTOFI, F.K., SOBIN, L.H., and TORLONI, H., Histologic typing of urinary bladders. In International histological classification of tumors. World Health Organisation, Geneva (1973). 36 pp.
20. NAKAMURA, T.M., MORIN, G.B., CHAPMAN, K.B., WEINRICH, S.L., ANDREWS, W.H., LINGNER, J., HARLEY, C.B., and CECH, T.R., Telomerase catalytic subunit homologs from fission yeast and human. Science, 277, 955-959 (1997).
21. NAKAYAMA, J., TAHARA, H., TAHARA, E., SAITO, M., ITO, K., NAKAMURA, H., NAKANISHI, T., IDE, T., and ISHIKAWA, F., Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nature (Genet.), 18, 65-68 (1998).
22. OOMS, E.C., ANDERSON, W.A., ALONS, C.L., BOON, M.E., and VELDHUIZEN, R. W., Analysis of the performance of pathologists in the grading of bladder tumors. Hum. Pathol., 14, 140-143 (1983).
23. PARK, T.W., RIETHDORF, S., RIETHDORF, L., LONING, T., and JANICKE, F., Differential telomerase activity, expression of the telomerase catalytic sub-unit and telomerase-RNA in ovarian tumors. Int. J. Cancer, 84, 426-431 (1999).
24. RAHAT, M.A., LAHAT, N., GAZAWI, H., RESNICK, M.B., SOVA, Y., BEN-ARI ,G., COHEN, M., and STEIN, A., Telomerase activity in patients with transitional cell carcinoma: a preliminary study. Cancer, 85, 919-924 (1999).
25. ROBERTSON, A.J., BECK, J.S., BURNETT, R.A., HOWATSON, S.R., LEE, F.D., LESSELLES, A.M., MCLAREN, K.M., MOSS, S.M., SIMPSON, J.G., and SMITH, G.D., Observer variability in histopathological reporting of transitional cell carcinoma and epithelial dysplasia in bladders. J. clin. Pathol., 43, 17-21 (1990).
26. SCHAPERS, R.F., PAUWELS, R.P., WIJNEN, J.T., ARENDS, J.W., THUNNISSEN, F.B., COEBERGH, J.W., SMEETS, A.W., and BOSMAN, F.T., A simplified grading method of transitional cell carcinoma of the urinary bladder: reproducibility. clinical significance and COMPARISON WITH OTHER PROGNOSTIC PARAMETERS. Brit. J. Urol., 73, 625-631 (1994).
27. SCHER, H.I., SHIPLEY, W.U., and HERR, H.W., Cancer of the bladder. In V.T. DeVita, S. Hellman, and S.A. Rosenberg (eds.), Cancer: Principles and practice of oncology, 5th edition, pp. 1300-1322, Lippincott-Raven, Philadelphia (1997).
28. SPIESSL, B., BEAHRS, O.H., HERMANEK, P., HUTTER, R.V., SCHEIBE, O., and SOBIN, L.H., In TNM atlas: illustrated guide to the TNM/pTNM classification of malignant tumors, 3rd edition 2nd revision, pp. 274-279, Springer-Verlag, Berlin (1992).
29. WEINRICH, S.L., and 16 OTHERS, Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nature (Genet.), 17, 498-502 (1997).
30. WU, A., ICHIHASHI, M., and UEDA, M., Correlation of the expression of human telomerase subunits with telomerase activity in normal skin and skin tumors. Cancer, 86, 2038-2044 (1999)
31. YOKOTA, K., KANDA, K., INOUE, Y., KANAYAMA, H., and KAGAWA, S., Semi-quantitative analysis of telomerase activity in exfoliated human urothelial cells and bladder transitional cell carcinoma. Brit. J. Urol., 82, 727-732 (1998).
32. YOSHIDA, K., SUGINO, T., TAHARA, H., WOODMAN, A., BOLODEOKU, J., NAKGUND, V., FELLOWS, G., GOODISON, S., TAHARA, E., and TARIN, D., Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer, 79, 362-369 (1997).